<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Pneumonia Risk Stratification Tools</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->2/25/2011</div></div><div class="card__content"><h1 id="pneumonia-risk-stratification-scoring-tools">Pneumonia: Risk Stratification Scoring Tools</h1>
<h2 id="pneumonia-severity-index-psi-">Pneumonia Severity Index (PSI)</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086">Fine et al., JAMA 1997</a></p>
<ul>
<li>Pneumonia Patient Outcomes Research Team (PORT)</li>
<li>A large derivation and validation study with &gt;50,000 patients</li>
<li>Best identifies low-risk/ low-mortality patients</li>
<li>Tends to miss higher-risk pneumonia in younger patients because score is based on age </li>
<li>Does not factor in immunosuppression (eg. HIV) and poor social support </li>
</ul>
<table>
<thead>
<tr>
<th>Risk factors</th>
<th align="right">Points</th>
</tr>
</thead>
<tbody><tr>
<td>Men</td>
<td align="right">Age (years)</td>
</tr>
<tr>
<td>Women</td>
<td align="right">Age (years)-10</td>
</tr>
<tr>
<td>Nursing home resident</td>
<td align="right">+10</td>
</tr>
<tr>
<td>History of neoplasm</td>
<td align="right">+30</td>
</tr>
<tr>
<td>History of liver disease</td>
<td align="right">+20</td>
</tr>
<tr>
<td>History of heart failure</td>
<td align="right">+10</td>
</tr>
<tr>
<td>History of stroke</td>
<td align="right">+10</td>
</tr>
<tr>
<td>History of renal failure</td>
<td align="right">+10</td>
</tr>
<tr>
<td>Altered mental status</td>
<td align="right">+20</td>
</tr>
<tr>
<td>RR &ge; 30 breaths/ min</td>
<td align="right">+20</td>
</tr>
<tr>
<td>SBP &lt; 90 mmHg</td>
<td align="right">+20</td>
</tr>
<tr>
<td>Temp &lt; 95F (35C) or &ge;104F (40C)</td>
<td align="right">+15</td>
</tr>
<tr>
<td>HR &ge; 125 bpm</td>
<td align="right">+10</td>
</tr>
<tr>
<td>Arterial pH &lt; 7.35</td>
<td align="right">+30</td>
</tr>
<tr>
<td>BUN &gt; 30 mg/dL</td>
<td align="right">+20</td>
</tr>
<tr>
<td>Na &lt; 130 mmol/L</td>
<td align="right">+20</td>
</tr>
<tr>
<td>Glucose &ge;250 mg/dL</td>
<td align="right">+10</td>
</tr>
<tr>
<td>Hematocrit &lt; 30%</td>
<td align="right">+10</td>
</tr>
<tr>
<td>PaO2 &lt; 60 mmHg</td>
<td align="right">+10</td>
</tr>
<tr>
<td>Pleural effusion</td>
<td align="right">+10</td>
</tr>
</tbody></table>
<table>
<thead>
<tr>
<th>PSI Class</th>
<th align="right">Total Points</th>
<th align="right">30-Day Mortality</th>
<th>Disposition</th>
</tr>
</thead>
<tbody><tr>
<td>I</td>
<td align="right">&lt; 51</td>
<td align="right">0.1%</td>
<td>Outpatient</td>
</tr>
<tr>
<td>II</td>
<td align="right">51-70</td>
<td align="right">0.6%</td>
<td>Outpatient</td>
</tr>
<tr>
<td>III</td>
<td align="right">71-90</td>
<td align="right">0.9%</td>
<td>Outpatient vs short-stay inpatient</td>
</tr>
<tr>
<td>IV</td>
<td align="right">91-130</td>
<td align="right">9.3%</td>
<td>Inpatient</td>
</tr>
<tr>
<td>V</td>
<td align="right">&gt; 130</td>
<td align="right">27.0%</td>
<td>Inpatient ICU</td>
</tr>
</tbody></table>
<h2 id="curb-65-severity-score">CURB-65 Severity Score</h2>
<p>Supported by (<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364">British Thoracic Society Standards of Care Committee</a> &amp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136"> </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136">Aujesky et al, Am J Med, 2005</a>) </p>
<ul>
<li>Best identifies high-risk/ high-mortality patients</li>
<li>Tends to misclassify moderate-risk pneumonia patients (as low-risk) </li>
<li>Does not account for co-morbidities and hypoxemia</li>
</ul>
<p>|        | Risk Factor                                     | Points |
| ------ | ----------------------------------------------- | -----: |
| <strong>C**  | **C</strong>onfusion                                   |      1 |
| <strong>U**  | Uremia (BUN &gt;19 mg/dL)                          |      1 |
| **R</strong>  | <strong>R*<em>R &ge; 30 breaths/min                      |      1 |
| *</em>B</strong>  | <strong>B*<em>P low (SBP &lt;90 mmHg or DBP &lt;60 mmHg) |      1 |
| *</em>65</strong> | Age &ge; <strong>65</strong> years                           |      1 |</p>
<table>
<thead>
<tr>
<th align="right">Total Points</th>
<th align="right">30-Day Mortality</th>
<th>Disposition</th>
</tr>
</thead>
<tbody><tr>
<td align="right">0</td>
<td align="right">0.6%</td>
<td>Outpatient</td>
</tr>
<tr>
<td align="right">1</td>
<td align="right">3.2%</td>
<td>Outpatient</td>
</tr>
<tr>
<td align="right">2</td>
<td align="right">13.0%</td>
<td>Outpatient or short-stay inpatient</td>
</tr>
<tr>
<td align="right">3</td>
<td align="right">17.0%</td>
<td>Inpatient</td>
</tr>
<tr>
<td align="right">4</td>
<td align="right">41.5%</td>
<td>Inpatient, likely ICU</td>
</tr>
<tr>
<td align="right">5</td>
<td align="right">57.0%</td>
<td>Inpatient ICU</td>
</tr>
</tbody></table>
<h2 id="smart-cop">SMART-COP</h2>
<p>Supported by Australian CAP Study (<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884">Charles et al., Clin Infect Dis, 2008</a>)</p>
<ul>
<li>Tool to predict need for intensive respiratory or vasopressor support (IRVS) </li>
</ul>
<table>
<colgroup>
<col width="33%" />
<col width="33%" />
<col width="33%" />
</colgroup>
<thead>
<tr class="header">
<th><br />
</th>
<th><strong>Risk factor</strong></th>
<th><strong>Points</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>S</strong></td>
<td><strong>S</strong>ystolic BP &lt; 90 mmHg</td>
<td>2</td>
</tr>
<tr class="even">
<td><strong>M</strong></td>
<td><strong>M</strong>ultilobar CXR involvement</td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>A</strong></td>
<td><strong>A</strong>lbumin &lt; 3.5 g/dL</td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>R</strong></td>
<td>If age &le; 50 years: <strong>R</strong>R &ge; 25 breaths/min <br />
If age &gt; 50 years: <strong>R</strong>R &ge; 30 breaths min <br />
</td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>T</strong></td>
<td><strong>T</strong>achycardia HR &ge; 125 bpm </td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>C</strong></td>
<td><strong>C</strong>onfusion (new onset)</td>
<td>1<br />
</td>
</tr>
<tr class="odd">
<td><strong>O</strong></td>
<td><strong>O</strong>xygen low<br />

<p>If age &le;50 years: </p>
<ul>
<li>PaO2 &lt; 70 mmHg, or<br />
</li>
<li>O2 sat &le; 93%, or<br />
</li>
<li>PaO2/FiO2 &lt; 333<br />
</li>
</ul>
<p>If age &gt;50 years:</p>
<ul>
<li>PaO2 &lt; 60 mmHg, or</li>
<li>O2 sat &le; 90%, or </li>
<li>PaO2/FiO2 &lt; 250 </li>
</ul></td>
<td>2</td>
</tr>
<tr class="even">
<td><strong>P</strong></td>
<td>Arterial <strong>p</strong>H &lt; 7.35</td>
<td>2</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr>
<th align="right">Total points</th>
<th>Risk of needing IRVS</th>
</tr>
</thead>
<tbody><tr>
<td align="right">0-2</td>
<td>Low</td>
</tr>
<tr>
<td align="right">3-4</td>
<td>Moderate (1 in 8)</td>
</tr>
<tr>
<td align="right">5-6</td>
<td>High (1 in 3)</td>
</tr>
<tr>
<td align="right">&ge; 7</td>
<td>Very high (2 in 3)</td>
</tr>
</tbody></table>
<h2 id="references">References</h2>
<ul>
<li>Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. <em>Am J Med</em>. 2005 Apr;118(4):384-92. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136">PubMed</a>]</li>
<li>Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia. <em>N Engl J Med</em>. 1997 Jan 23;336(4):243-50. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086">PubMed</a>]</li>
<li>Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. <em>Clin Infect Dis</em>. 2008 Aug 1;47(3):375-84. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884">PubMed</a>]</li>
<li>British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. <em>Thorax</em>. 2001 Dec;56 Suppl 4:IV1-64. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"pneumonia-severity","title":"Pneumonia Risk Stratification Tools","authors":["Michelle Lin, MD"],"categories":[{"slug":"pulmonology","name":"Pulmonology"},{"slug":"infectious-disease","name":"Infectious Disease"},{"slug":"ebm","name":"EBM"}],"created":"2011/02/25","updated":null,"body":"\n# Pneumonia: Risk Stratification Scoring Tools\n\n## Pneumonia Severity Index (PSI) \n\n[Fine et al., JAMA 1997](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)\n- Pneumonia Patient Outcomes Research Team (PORT)\n- A large derivation and validation study with \u003e50,000 patients\n- Best identifies low-risk/ low-mortality patients\n- Tends to miss higher-risk pneumonia in younger patients because score is based on age \n- Does not factor in immunosuppression (eg. HIV) and poor social support \n\n| Risk factors                           |         Points |\n| -------------------------------------- | -------------: |\n| Men                                    |    Age (years) |\n| Women                                  | Age (years)-10 |\n| Nursing home resident                  |            +10 |\n| History of neoplasm                    |            +30 |\n| History of liver disease               |            +20 |\n| History of heart failure               |            +10 |\n| History of stroke                      |            +10 |\n| History of renal failure               |            +10 |\n| Altered mental status                  |            +20 |\n| RR \u0026ge; 30 breaths/ min                |            +20 |\n| SBP \u0026lt; 90 mmHg                       |            +20 |\n| Temp \u0026lt; 95F (35C) or \u0026ge;104F (40C)  |            +15 |\n| HR \u0026ge; 125 bpm                        |            +10 |\n| Arterial pH \u0026lt; 7.35                  |            +30 |\n| BUN \u0026gt; 30 mg/dL                      |            +20 |\n| Na \u0026lt; 130 mmol/L                     |            +20 |\n| Glucose \u0026ge;250 mg/dL                  |            +10 |\n| Hematocrit \u0026lt; 30%                    |            +10 |\n| PaO2 \u0026lt; 60 mmHg                      |            +10 |\n| Pleural effusion                       |            +10 |\n\n| PSI Class | Total Points | 30-Day Mortality | Disposition                        |\n| --------- | -----------: | ---------------: | ---------------------------------- |\n| I         |      \u0026lt; 51 |             0.1% | Outpatient                         |\n| II        |        51-70 |             0.6% | Outpatient                         |\n| III       |        71-90 |             0.9% | Outpatient vs short-stay inpatient |\n| IV        |       91-130 |             9.3% | Inpatient                          |\n| V         |     \u0026gt; 130 |            27.0% | Inpatient ICU                      |\n\n## CURB-65 Severity Score\n\nSupported by ([British Thoracic Society Standards of Care Committee](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364) \u0026[ ](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)[Aujesky et al, Am J Med, 2005](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)) \n\n- Best identifies high-risk/ high-mortality patients\n- Tends to misclassify moderate-risk pneumonia patients (as low-risk) \n- Does not account for co-morbidities and hypoxemia\n\n|        | Risk Factor                                     | Points |\n| ------ | ----------------------------------------------- | -----: |\n| **C**  | **C**onfusion                                   |      1 |\n| **U**  | Uremia (BUN \u003e19 mg/dL)                          |      1 |\n| **R**  | **R**R \u0026ge; 30 breaths/min                      |      1 |\n| **B**  | **B**P low (SBP \u0026lt;90 mmHg or DBP \u0026lt;60 mmHg) |      1 |\n| **65** | Age \u0026ge; **65** years                           |      1 |\n\n| Total Points | 30-Day Mortality | Disposition                        |\n| -----------: | ---------------: | ---------------------------------- |\n|            0 |             0.6% | Outpatient                         |\n|            1 |             3.2% | Outpatient                         |\n|            2 |            13.0% | Outpatient or short-stay inpatient |\n|            3 |            17.0% | Inpatient                          |\n|            4 |            41.5% | Inpatient, likely ICU              |\n|            5 |            57.0% | Inpatient ICU                      |\n\n## SMART-COP\n\nSupported by Australian CAP Study ([Charles et al., Clin Infect Dis, 2008](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884))\n\n- Tool to predict need for intensive respiratory or vasopressor support (IRVS) \n\n\u003ctable\u003e\n\u003ccolgroup\u003e\n\u003ccol width=\"33%\" /\u003e\n\u003ccol width=\"33%\" /\u003e\n\u003ccol width=\"33%\" /\u003e\n\u003c/colgroup\u003e\n\u003cthead\u003e\n\u003ctr class=\"header\"\u003e\n\u003cth\u003e\u003cbr /\u003e\n\u003c/th\u003e\n\u003cth\u003e\u003cstrong\u003eRisk factor\u003c/strong\u003e\u003c/th\u003e\n\u003cth\u003e\u003cstrong\u003ePoints\u003c/strong\u003e\u003c/th\u003e\n\u003c/tr\u003e\n\u003c/thead\u003e\n\u003ctbody\u003e\n\u003ctr class=\"odd\"\u003e\n\u003ctd\u003e\u003cstrong\u003eS\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003eS\u003c/strong\u003eystolic BP \u0026lt; 90 mmHg\u003c/td\u003e\n\u003ctd\u003e2\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"even\"\u003e\n\u003ctd\u003e\u003cstrong\u003eM\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003eM\u003c/strong\u003eultilobar CXR involvement\u003c/td\u003e\n\u003ctd\u003e1\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"odd\"\u003e\n\u003ctd\u003e\u003cstrong\u003eA\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003eA\u003c/strong\u003elbumin \u0026lt; 3.5 g/dL\u003c/td\u003e\n\u003ctd\u003e1\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"even\"\u003e\n\u003ctd\u003e\u003cstrong\u003eR\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003eIf age \u0026le; 50 years: \u003cstrong\u003eR\u003c/strong\u003eR \u0026ge; 25 breaths/min \u003cbr /\u003e\nIf age \u0026gt; 50 years: \u003cstrong\u003eR\u003c/strong\u003eR \u0026ge; 30 breaths min \u003cbr /\u003e\n\u003c/td\u003e\n\u003ctd\u003e1\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"odd\"\u003e\n\u003ctd\u003e\u003cstrong\u003eT\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003eT\u003c/strong\u003eachycardia HR \u0026ge; 125 bpm \u003c/td\u003e\n\u003ctd\u003e1\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"even\"\u003e\n\u003ctd\u003e\u003cstrong\u003eC\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003eC\u003c/strong\u003eonfusion (new onset)\u003c/td\u003e\n\u003ctd\u003e1\u003cbr /\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"odd\"\u003e\n\u003ctd\u003e\u003cstrong\u003eO\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003e\u003cstrong\u003eO\u003c/strong\u003exygen low\u003cbr /\u003e\n\n\u003cp\u003eIf age \u0026le;50 years: \u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003ePaO2 \u0026lt; 70 mmHg, or\u003cbr /\u003e\n\u003c/li\u003e\n\u003cli\u003eO2 sat \u0026le; 93%, or\u003cbr /\u003e\n\u003c/li\u003e\n\u003cli\u003ePaO2/FiO2 \u0026lt; 333\u003cbr /\u003e\n\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eIf age \u0026gt;50 years:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003ePaO2 \u0026lt; 60 mmHg, or\u003c/li\u003e\n\u003cli\u003eO2 sat \u0026le; 90%, or \u003c/li\u003e\n\u003cli\u003ePaO2/FiO2 \u0026lt; 250 \u003c/li\u003e\n\u003c/ul\u003e\u003c/td\u003e\n\u003ctd\u003e2\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr class=\"even\"\u003e\n\u003ctd\u003e\u003cstrong\u003eP\u003c/strong\u003e\u003c/td\u003e\n\u003ctd\u003eArterial \u003cstrong\u003ep\u003c/strong\u003eH \u0026lt; 7.35\u003c/td\u003e\n\u003ctd\u003e2\u003c/td\u003e\n\u003c/tr\u003e\n\u003c/tbody\u003e\n\u003c/table\u003e\n\n| Total points | Risk of needing IRVS |\n| -----------: | -------------------- |\n|          0-2 | Low                  |\n|          3-4 | Moderate (1 in 8)    |\n|          5-6 | High (1 in 3)        |\n|       \u0026ge; 7 | Very high (2 in 3)   |\n\n## References\n\n- Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. _Am J Med_. 2005 Apr;118(4):384-92. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)]\n- Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia. _N Engl J Med_. 1997 Jan 23;336(4):243-50. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)]\n- Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. _Clin Infect Dis_. 2008 Aug 1;47(3):375-84. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884)]\n- British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. _Thorax_. 2001 Dec;56 Suppl 4:IV1-64. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"pneumonia-severity"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>